NCT03609931

Brief Summary

Mitral valve disease is a common pathologic problem occurring in approximately 2% of the general population but climbing to 10% in those over the age of 75 in Canada\[1\]. This project has three primary goals all of which will positively affect cardiac patient care. 1\) Create patient specific MV models for complex repairs that will allow surgeons the opportunity to practice the repair. 2) Potentially predict the outcomes following minimally invasive repair techniques such as transcatheter treatments (e.g., MitraClip). 3) Provide a model to train individuals on mitral valve repair techniques.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
65

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 12, 2018

Completed
19 days until next milestone

Study Start

First participant enrolled

July 1, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
Last Updated

August 1, 2018

Status Verified

July 1, 2018

Enrollment Period

1.1 years

First QC Date

June 12, 2018

Last Update Submit

July 31, 2018

Conditions

Keywords

Mitral Valve

Outcome Measures

Primary Outcomes (1)

  • MR following patient/model repair

    The degree and location of residual MR following mitral repair surgery

    Creation and assessment of the model within 1 week before or after surgery/intervention on the patient.

Secondary Outcomes (19)

  • 2D measurements of the mitral valve: Anterolateral-Posteromedial Diameter

    Assessment of model within 1 week of surgical or interventional repair on the patient

  • 2D measurements of the mitral valve:Annular Height

    Assessment of model within 1 week of surgical or interventional repair on the patient

  • 2D measurements of the mitral valve: Annular 3D Circumference

    Assessment of model within 1 week of surgical or interventional repair on the patient

  • 2D measurements of the mitral valve:Annular 2D Area

    Assessment of model within 1 week of surgical or interventional repair on the patient

  • 2D measurements of the mitral valve: Annular Ellipticity

    Assessment of model within 1 week of surgical or interventional repair on the patient

  • +14 more secondary outcomes

Study Arms (1)

Mitral Valve repair

Patients undergoing mitral valve repair

Procedure: Mitral Valve Model

Interventions

Creation of a mitral valve patient specific model to see if it mimics the patients valve

Mitral Valve repair

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients with mitral regurgitation scheduled to undergo mitral valve repair with either a open heart surgical technique or with a MitraClip

You may qualify if:

  • Patients undergo mitral valve repair with either surgery of MitraClip techniques
  • Over 18 years old

You may not qualify if:

  • Unable to place TEE probe
  • Refuse consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Ginty O, Moore J, Peters T, Bainbridge D. Modeling Patient-Specific Deformable Mitral Valves. J Cardiothorac Vasc Anesth. 2018 Jun;32(3):1368-1373. doi: 10.1053/j.jvca.2017.09.005. Epub 2017 Sep 7.

    PMID: 29221976BACKGROUND

MeSH Terms

Conditions

Mitral Valve ProlapseMitral Valve Insufficiency

Condition Hierarchy (Ancestors)

Heart Valve ProlapseHeart Valve DiseasesHeart DiseasesCardiovascular Diseases

Central Study Contacts

Daniel Bainbridge, MD FRCPC

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 12, 2018

First Posted

August 1, 2018

Study Start

July 1, 2018

Primary Completion

August 1, 2019

Study Completion

January 1, 2020

Last Updated

August 1, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share